Status:
UNKNOWN
Role of NGAL in Vitiligo
Lead Sponsor:
Sohag University
Conditions:
Vitiligo
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Role of serum Neutrophil Gelatinase-associated Lipocalin in early detection of cardiovascular risk in patients with Vitiligo
Eligibility Criteria
Inclusion
- patients with vitiligo above 20y
Exclusion
- patients with systemic disease Pregnants female Lactating females Patients less than 20 y Patients with active lesions
Key Trial Info
Start Date :
December 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05290077
Start Date
December 15 2022
End Date
December 15 2022
Last Update
October 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag fuculty
Sohag, Egypt